Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Factors Affecting Protein-Drug Binding: Drug Interactions01:23

Factors Affecting Protein-Drug Binding: Drug Interactions

163
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
163
Protein-protein Interfaces02:04

Protein-protein Interfaces

12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

523
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
523
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

167
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
167
Protein Networks02:26

Protein Networks

4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Nuclear import of malaria RNA rewires splicing in host immune cells.

Cell reports·2026
Same author

A pharmacological modality to sequester homomeric proteins.

Nature chemical biology·2026
Same author

Bridging or exchanging partners? A supramolecular perspective on bifunctional molecules and their potential for triggerable enzyme therapy.

Current opinion in chemical biology·2026
Same author

Quantification and characterization of extracellular vesicles by flow cytometry.

Current topics in membranes·2025
Same author

Polyphosphocholination of liposomic vehicles extends blood circulation, enhances cellular uptake, and lowers immunogenicity relative to PEGylation.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Low-Background His-Tag-Targeting Probes for Turn-On Fluorescence Detection of Cell Surface Proteins and Their Binding Interactions.

Small (Weinheim an der Bergstrasse, Germany)·2025

相关实验视频

Updated: Jul 10, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K

人工蛋白与一个分子交换结合伙伴的分子交叉通话.

Ohad Suss1, Olga Halfin1, Ziv Porat2

  • 1Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot, 7610001, Israel.

Angewandte Chemie (International ed. in English)
|November 27, 2023
PubMed
概括

科学家们创造了一种新的方法来控制细胞中的酶活性,使用合成调节剂. 这种方法将酶功能与细胞氧气水平联系起来,模仿自然信号通路.

关键词:
人工激活酶的人工激活酶蛋白质表面识别 蛋白质表面识别超分子化学 超分子化学

更多相关视频

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.7K
Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.3K

相关实验视频

Last Updated: Jul 10, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
13:00

Engineering Antiviral Agents via Surface Plasmon Resonance

Published on: June 14, 2022

2.4K
Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study
12:43

Genetic and Biochemical Approaches for In Vivo and In Vitro Assessment of Protein Oligomerization: The Ryanodine Receptor Case Study

Published on: July 27, 2016

11.7K
Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.3K

科学领域:

  • 生物化学 生物化学
  • 合成生物学 合成生物学
  • 酶工程是什么? 酶工程是什么?

背景情况:

  • 阿洛斯特酶通过催化和调节单元之间的非共价相互作用来调节细胞过程.
  • 了解和模仿这些自然信号机制对于开发新的治疗策略至关重要.
  • 糖原合成酶激酶3 (GSK-3) 和乳酸脱酶A (LDHA) 是参与细胞代谢和对环境线索的反应的关键酶.

研究的目的:

  • 设计一种方法来确定在原生细胞内以效应体为媒介的非自然酶激活.
  • 为了证明这种方法的可行性,使用糖原合成酶激酶3 (GSK-3) 和乳酸脱酶A (LDHA).
  • 创建一种合成调节系统,将酶活性与细胞氧气水平联系起来.

主要方法:

  • 在GSK-3上通过非共价接引入一个合成调节单元 (sRU).
  • 在GSK-3和LDHA之间设计非自然的交叉声.
  • 利用LDHA作为一个效应蛋白来控制基于细胞氧气水平的GSK-3活性.

主要成果:

  • GSK-3成功地从构成性活性酶转化为可激活的酶.
  • LDHA被重新定位为一种非自然的效应因子,在对低氧反应中调解GSK-3活性.
  • 证明GSK-3和LDHA之间非自然的交叉声,由细胞氧气水平控制.

结论:

  • 这项研究提出了一种创新的方法,可以在活细胞内制造受效器调节的酶,模仿自然的全信号传递.
  • 这些发现为开发新类蛋白质抑制剂铺平了道路,其活性依赖于环境.
  • 这种方法为通过合成酶调节来设计细胞对环境变化的反应提供了原则证明.